The Garvan Institute is internationally recognised for its pioneering research into uncovering the molecular events of disease. Garvan is committed to translating its discoveries to improving health outcomes, with novel therapeutics, diagnostics and personalised medicine. We work with industry partners, supplying our expert capabilities to enhance drug and diagnostics discovery and development. Our close links to St Vincent’s Hospital provides access to patients, with many of our researchers holding clinical appointments.
Garvan has a rich history of driving medical research innovation with external partners. We have established productive collaborations with HealthLinx, CRC for Cancer Therapeutics the Shanghai Institute of Biological Sciences, Auckland UniServices, Genentech, Roche, Novo Nordisk, Clarient and Novartis amongst others
Discover our key research interests and capabilities for collaborative R&D across the institute by following the links below:
- Research Facilities and Capabilities
- Bone Biology Division
- Cancer Division
- Diabetes and Metabolism Division
- Genomics and Epigenetics Division
- Immunology Division
- Neuroscience Division
- Kinghorn Centre for Clinical Genomics
For further information please contact the Partnerships team.